BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 3213023)

  • 21. IgA containing immune complexes in rheumatoid vasculitis and in active rheumatoid disease.
    Westedt ML; Daha MR; de Vries E; Valentijn RM; Cats A
    J Rheumatol; 1985 Jun; 12(3):449-55. PubMed ID: 4045842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of complement activating circulating immune complexes and an example for antigen specific immune complex assays.
    Krapf F; Fuchs C; Herrmann M; Hoferichter S; Kalden JR
    J Clin Lab Immunol; 1986 Dec; 21(4):183-7. PubMed ID: 3550093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demonstration of circulating and tissue-fixed immune complexes in cutaneous necrotizing vasculitis.
    Imamura S; Yanase K
    Acta Derm Venereol; 1980; 60(5):389-92. PubMed ID: 6162308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the mechanism producing solubilization of immune precipitates in the serum of patients with primary IgA nephropathy.
    Schena FP; Pastore A; Sinico RA; Ladisa N; Montinaro V; Fornasieri A
    Semin Nephrol; 1987 Dec; 7(4):336-40. PubMed ID: 3445011
    [No Abstract]   [Full Text] [Related]  

  • 25. Detection of IgA dominant immune complexes on peripheral blood lymphocytes in patients with IgA nephropathy.
    Nomoto H; Tomino Y; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1986 Mar; 11(1):13-7. PubMed ID: 3544343
    [No Abstract]   [Full Text] [Related]  

  • 26. Detection of IgA-class circulating immune complexes (CIC) in sera from patients with IgA nephropathy using a solid-phase anti-C3 Facb enzyme immunoassay (EIA).
    Yagame M; Tomino Y; Miura M; Tanigaki T; Suga T; Nomoto Y; Sakai H
    Clin Exp Immunol; 1987 Feb; 67(2):270-6. PubMed ID: 3301093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spatial arrangement of IgA and C3 as a prognostic indicator of IgA nephropathy.
    Muda AO; Feriozzi S; Rahimi S; Faraggiana T
    J Pathol; 1995 Oct; 177(2):201-8. PubMed ID: 7490687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoantibodies, immunoglobulins, complement and circulating immune complexes in acute malaria.
    Jhaveri KN; Ghosh K; Mohanty D; Parmar BD; Surati RR; Camoens HM; Joshi SH; Iyer YS; Desai A; Badakere SS
    Natl Med J India; 1997; 10(1):5-7. PubMed ID: 9069696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of ageing on the immune response to Schistosoma haematobium and hookworm by measuring circulating immune complexes, C3, IgG, IgA and IgM levels in residents of Omi dam area of Kogi State, Nigeria.
    Oyeyinka GO; Awogun IA; Akande TM; Awarun JA; Arinola OG; Salimonu LS
    Afr J Med Med Sci; 2003 Sep; 32(3):263-7. PubMed ID: 15030085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Complement and serum immunoglobulins in homozygous and heterozygous sickle cell anemia in Senegal].
    Dieye TN; Ndiaye O; Ndiaye AB; Thiam D; Fall-Seck K; Diop S; Diop BM; Fall M; Diakhaté L
    Dakar Med; 1999; 44(2):175-9. PubMed ID: 11957280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A new etiology of episcleritis: nephropathies with IgA and/or isolated C3 deposits].
    Sirbat D; Saudax E; Hurault de Ligny B; Bene MC; Raspiller A
    J Fr Ophtalmol; 1983; 6(11):921-5. PubMed ID: 6368661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunological studies of glomerulonephritis].
    Belovezhdov N; Altŭnkova I
    Vutr Boles; 1981; 20(4):38-46. PubMed ID: 7303639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of circulating immune complexes in patients with glomerulonephritis.
    Szewczyk Z; Falkiewicz K; Kopeć W
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):577-81. PubMed ID: 373683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating immune complexes and serum immunoglobulins in acute poststreptococcal glomerulonephritis.
    Rodríguez-Iturbe B; Carr RI; García R; Rabideau D; Rubio L; McIntosh RM
    Clin Nephrol; 1980 Jan; 13(1):1-4. PubMed ID: 7363511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymeric IgA and IgA rheumatoid factor decrease the capacity of serum to solubilize circulating immune complexes in patients with primary IgA nephropathy.
    Schena PF; Pastore A; Sinico RA; Montinaro V; Fornasieri A
    J Immunol; 1988 Jul; 141(1):125-30. PubMed ID: 3379302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arthritis associated with chronic active hepatitis: complement activation and characterization of circulating immune complexes.
    Wands JR; Alpert E; Isselbacher KJ
    Gastroenterology; 1975 Dec; 69(6):1286-91. PubMed ID: 1193327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous immunofluorescence in ankylosing spondylitis. Absence of correlation with disease activity.
    Peeters AJ; Boom BW; de Rooy-Dijk HH; Westedt ML; Breedveld FC
    J Rheumatol; 1990 Feb; 17(2):234-7. PubMed ID: 2181128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoglobulin and complement deposits in the skin and circulating immune complexes in scabies.
    Salo OP; Reunala T; Kalimo K; Rantanen T
    Acta Derm Venereol; 1982; 62(1):73-6. PubMed ID: 6175145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunologic changes in chronic pancreatitis].
    Del Favero G; Meani A; Zaccaria F; De Lazzari F; Piccoli A; Farini A; Fabris C; Chiaramonte M; Pedrazzoli S; Farini R; Naccarato R
    Minerva Med; 1983 Jul; 74(28-29):1739-43. PubMed ID: 6408533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune complexes in patients with drug eruptions: the relationship between skin lesions and circulating immune complexes.
    Yanase K; Imamura S
    Clin Exp Immunol; 1980 Sep; 41(3):471-7. PubMed ID: 6449338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.